Trientine hydrochloride is under clinical development by Innolife and currently in Phase II for Coronary Artery Disease (CAD) (Ischemic Heart Disease).
Market Segmentation Clarity: The research aims to bring clarity to market segmentation by scrutinizing distinct segments within the industry. This involves identifying unique characteristics and ...